Effects of a selective 2 -adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo

By Laitinen K.S.M.   Tuomisto L.   MacDonald E.  

European Journal of Pharmacology, Vol. 285, Iss. 3, 1995-10 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

GABA B receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro

By Nyitrai G.   Kekesi K.A.   Emri Z.   Szarics E.   Juhasz G.   Kardos J.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 111-119

Elsevier

Access to resources Recommend Favorite

Melatonin release from rat pineals in vitro is stimulated by both the 2 -adrenoceptor agonist medetomidine and the antagonist atipamezole

By Mustanoja S.M.   Back N.   Alila-Johansson A.   Laakso M.-L.  

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 75-82

Elsevier

Access to resources Recommend Favorite

Atipamezole, an 2 -adrenoceptor antagonist, augments the effects of l-DOPA on evoked dopamine release in rat striatum

By Yavich L.   Sirvio J.   Haapalinna A.   Ylinen A.   Mannisto P.T.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

Determination of the somatodendritic 2 -adrenoceptor subtype located in rat locus coeruleus that modulates cortical noradrenaline release in vivo

By Mateo Y.   Meana J.J.  

European Journal of Pharmacology, Vol. 379, Iss. 1, 1999-08 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite